The 20 Best Oral Squamous Cell Carcinoma Doctors Near Me in Ann Arbor, MI

Brent B. Ward, DDS, MD, is the Chalmers J. Lyons Endowed Professor in the Department of Oral and Maxillofacial Surgery/Hospital Dentistry within the School of Dentistry, and Professor in the Section of Oral and Maxillofacial Surgery in the Department of Surgery at the University of Michigan. Dr. Ward is a graduate of Brigham Young University and the University of Southern California, Los Angeles School of Dentistry. He received his medical degree and completed his postgraduate training, including residency and fellowship, at the University of Michigan, joining the faculty in 2003. He is the Associate Program Director of the Oral/Head & Neck Oncologic and Microvascular Reconstructive Surgery Fellowship within the Section of Oral and Maxillofacial Surgery. Dr. Ward has been recognized as a professional leader by numerous organizations. He is a past president and the current Executive Director of the American Academy of Craniomaxillofacial Surgeons. He has held multiple leadership positions in the American Association of Oral and Maxillofacial Surgeons (AAOMS), including Chair of the Committee on Education and Training, the Committee on Oral, Head and Neck Oncology & Reconstructive Surgery, and the Special Committee on Student Recruitment and Residency Program Strategies. He currently chairs the Oral and Maxillofacial Surgery Foundation Research Committee and is a member of the Editorial Board of the Journal of Oral and Maxillofacial Surgery. Dr. Ward is the recipient of the 2025 Presidential Achievement Award from AAOMS. Throughout his career, Dr. Ward has actively blended his clinical expertise with research supported by entities including the National Institutes of Health, the Department of Defense, the OMS Foundation, and the Osteo Science Foundation, in the areas of cancer, reconstruction, and pain control. He specializes clinically in cancer and precancerous conditions, as well as major pathology and reconstruction of the structures of the face, mouth, and jaws resulting from cancer, trauma, or congenital defects. Dr. Ward is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Tongue Cancer, Mouth Ulcers, Gastrostomy, and Glossectomy. Dr. Ward is board certified in Oral & Maxillofacial Surgery.

Keith Casper is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Casper is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy. Dr. Casper is board certified in Otolaryngology-Head & Neck Surgery.

Paul L. Shivers, DMD, MD is a faculty member in the Department of Oral and Maxillofacial Surgery/Hospital Dentistry within the Department of Surgery at the University of Michigan Hospitals. He earned his bachelor’s degree from The Ohio State University and his dental degree from Case Western Reserve University. He subsequently received his medical degree and completed residency training in oral and maxillofacial surgery at Case Western Reserve. Following residency, he pursued fellowship training in oral/head and neck oncology and microvascular reconstructive surgery at the University of Michigan.Dr. Shivers currently serves as the Program Director of the Oral/Head and Neck Oncology and Microvascular Reconstructive Surgery Fellowship within the Section of Oral and Maxillofacial Surgery. Dr. Shivers is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Mouth Ulcers, Mouth Sores, Tissue Biopsy, and Glossectomy. Dr. Shivers is board certified in Oral & Maxillofacial Surgery.

Paul Swiecicki is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Swiecicki is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Oral Squamous Cell Carcinoma. Dr. Swiecicki is board certified in Medical Oncology.

Dr. Mierzwa has 8 years of clinical experience in treatment of head and neck as well as gastrointestinal cancers. Her clinical research interests have included novel chemoradiation regimens for head and neck cancers as well as pancreatic cancer. Specifically, she is currently in collaboration with the Department of Otolaryngology as part of a clinical trial to identify radiographic and serum biomarkers for oropharynx cancer patients who may be eligible for de-escalation of chemoradiation. Dr. Mierzwa is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Dry Mouth, and Pancreaticoduodenectomy. Dr. Mierzwa is board certified in Radiation Oncology.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Marisa Buchakjian is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Buchakjian is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Tongue Cancer, Throat Cancer, Laryngeal Cancer, Laryngectomy, and Tissue Biopsy. Dr. Buchakjian is board certified in Otolaryngology-Head & Neck Surgery.

Kelly Malloy is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Malloy is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Osteotomy.

Dr. Mark Prince earned his medical degree at Dalhousie University Medical School in Halifax, Nova Scotia, and then served with the Canadian Armed Forces as a medical officer, receiving specialized training in hyperbaric and diving medicine. Dr. Prince returned to Dalhousie University and completed a residency in otolaryngology head and neck surgery, followed by a two-year fellowship in advanced head and neck oncology and microvascular reconstructive surgery at the University of Michigan. He joined the University of Michigan faculty in 2000, and is actively involved in resident and medical student education, serving as his department's residency program director. Dr. Prince served as the chief of the section of otolaryngology at the Ann Arbor VA Medical Center until 2009, he continues to serve there as an active staff member. His research laboratory published the first report of the identification of cancer stem cells in head and neck squamous cell cancer, and continues to conduct research in this exciting field. Dr. Prince is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, and Gastrostomy. Dr. Prince is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Chaz Stucken is an associate professor of otolaryngology- head & neck surgery at the University of Michigan. He is dual-fellowship trained in both head & neck cancer surgery as well as facial plastic & reconstructive surgery. Dr. Stucken completed an accelerated 7-year B.A./M.D. at Boston University, earning his M.D. in 2008. He subsequently completed his training in otolaryngology-head & neck surgery at The Mount Sinai Hospital in New York City, where he received the Chairman’s Award at the completion of residency. Dr. Stucken then earned sub-specialty fellowship training in head & neck oncologic & microvascular surgery at the University of Michigan and in Facial Plastic & Reconstructive Surgery at Ohio State University. Throughout his training, Dr. Stucken received awards for excellence in research and clinical care. He has published several book chapters and scholarly articles in otolaryngology texts and peer-reviewed journals. Dr. Stucken is involved in humanitarian outreach work and has traveled to Guatemala to perform cleft lip surgery. He is dedicated to serving Spanish-speaking patients in southeast Michigan. He has given numerous presentations at conferences around the country, taught at instructional courses for other surgeons, and has been an invited faculty member to symposium on facial plastic & reconstructive surgery. He is an active member of the American Academy of Otolaryngology- Head & Neck Surgery and the American Academy of Facial Plastic & Reconstructive Surgery. He serves on several national committees including the Plastic & Reconstructive Surgery Committee, Microvascular Surgery Committee, and Humanitarian Efforts Committee.Dr. Stucken is committed to providing the highest level of care to his patients. He is also working to discover medical and surgical breakthroughs by collaborating with other surgeons and researchers throughout the medical center. He works closely with cutaneous oncology surgeons to provide optimal skin cancer treatments and reconstruction. As a member of the Comprehensive Head & Neck Cancer Team, he works closely with medical oncologists and radiation oncologists and enrolls patients in the most advanced clinical trials. Surgically, his subspecialty training gives him the opportunity to provide specialized care for every patient in order to obtain the best possible outcomes. Dr. Stucken is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Melanoma, Laryngectomy, and Tissue Biopsy. Dr. Stucken is board certified in Otolaryngology-Head & Neck Surgery and Facial Plastic & Recon Surg.

Andrew G. Shuman, MD, FACS, HEC-C is a head & neck cancer surgeon and a tenured Professor at the University of Michigan Medical School. He serves as chief of the clinical ethics service for Michigan Bioethics.He is the Assistant Dean for Veterans Affairs University of Michigan Medical School and the Associate Chief of Staff-Education at the VA Ann Arbor Health System, where he directs the educational experience for 1600 pre- and post-doctoral trainees and learners.Dr. Shuman is internationally recognized as a thought leader in ethical issues arising within the field of otolaryngology and surgical oncology. His work involves defining the conceptual dimensions of “surgical ethics,” applying his perspective as a practicing surgeon and clinical ethicist to normative and empirical bioethics research. He received extramural research funding for his work from NIH, the VA and societal grants, and has a portfolio of publications in leading journals in the fields of ethics, oncology and otolaryngology including The New England Journal of Medicine, JAMA and Nature Medicine. He has acted as PI on projects focused on cancer treatment decision-making, precision oncology and drug shortages, tailored to directly inform both the clinical practice and legal regulation of these ethically contentious and clinically complex disciplines. He was closely involved in Michigan Medicine and the VA's pandemic response, as well as at the state and national level on the ethics of scarce resource allocation including testifying in front of the United States Senate.Dr. Shuman completed fellowships in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center, and in medical ethics at Weill Medical College of Cornell University. He completed his residency in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. He is a graduate of the University of Michigan Medical School, and also graduated from the University of Michigan's College of Literature, Science and the Arts. Dr. Shuman is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Salivary Gland Tumors, and Laryngectomy. Dr. Shuman is board certified in Otolaryngology-Head & Neck Surgery.

Molly Neal is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Neal is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Glossectomy, and Laryngectomy.

Terri Bott-Kothari, MD has been in practice for over 16 years treating all disease sites. She completed her medical training at Wayne State University School of Medicine and residency at the University of Cincinnati. Dr. Bott is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Bott is board certified in Radiation Oncology.

Shamir Chandarana is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Chandarana is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Thyroid Cancer, Thyroidectomy, and Tissue Biopsy.

Avraham Eisbruch is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Eisbruch is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Dry Mouth, Head and Neck Squamous Cell Carcinoma (HNSCC), and Glossectomy.

Dr. Edwards is the James Hayward Endowed Clinical Professor of Oral & Maxillofacial Surgery and the Chief of Pediatric Oral and Maxillofacial Surgery, and Chair of Oral and Maxillofacial Surgery/Hospital Dentistry. He also serves as the chief of Pediatric Oral and Maxillofacial Surgery at C.S. Mott Children's Hospital. He graduated from the Dalhousie University School of Dentistry and the University of Michigan Medical School. Dr. Edwards completed his residency at the University of Michigan in Oral and Maxillofacial Surgery. After his residency, Dr. Edwards completed fellowship training at the University of Pittsburgh in Craniofacial Surgery and the University of Michigan in Oncology and Microvascular Reconstruction. Dr. Edwards' clinical interests include cleft lip and palate and craniofacial differences and pediatric head and neck oncology and survivorship. Dr. Edwards is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Osteochondroma, Cherubism, Prognathism, Osteotomy, and Myringotomy.

David Forner is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Forner is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Mikulicz Disease, Branchial Cleft Cyst, and Laryngectomy.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

I was born and raised in Michigan. I was an art minor in college and focused on drawing and painting. These days, I enjoy running and going on hikes with my family. Dr. Yalamanchi is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. Her clinical expertise encompasses Oral Squamous Cell Carcinoma, Palatopharyngeal Incompetence, Mikulicz Disease, and Salivary Gland Tumors.

Scott Mclean is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Mclean is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Teratocarcinosarcoma, Sinus Cancer, Tissue Biopsy, and Laryngectomy. Dr. Mclean is board certified in Otolaryngology-Head & Neck Surgery.